Biological evaluation of indolizine-chalcone hybrids as new anticancer agents

Sujin Park, Eun Hye Kim, Jinwoo Kim, Seong Hwan Kim, Ikyon Kim

Research output: Contribution to journalArticlepeer-review

66 Citations (Scopus)


A new chemical space was explored based on an indolizine-chalcone hybrid, which was readily accessible by base-mediated aldol condensation of indolizine bearing a 7-acetyl group with various (hetero)aromatic aldehydes. Their anticancer effect was evaluated, revealing that indolizine-chalcone hybrids with 3,5-dimethoxyphenyl group (4h) or the halogen at the meta position (4j and 4l) could have the potential to induce the caspase-dependent apoptosis of human lymphoma cells.

Original languageEnglish
Pages (from-to)435-443
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Publication statusPublished - 2018 Jan 20

Bibliographical note

Funding Information:
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) ( 2017R1A2A2A05069364 ) (to I.K.) and the Korea Research Institute of Chemical Technology project grant ( KK1703-F02 ) (to S.K.).

Publisher Copyright:
© 2017 Elsevier Masson SAS

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Biological evaluation of indolizine-chalcone hybrids as new anticancer agents'. Together they form a unique fingerprint.

Cite this